# Myokines as Potential Biomarkers and Drivers of Sarcopenia in Metabolic and Endocrine Diseases

> **NCT07703683** · — · RECRUITING · sponsor: **Cliniques universitaires Saint-Luc- Université Catholique de Louvain** · enrollment: 100 (estimated)

## Conditions studied

- Diabetes
- Obesity & Overweight
- Cushing Syndrome
- Metabolic Diseases
- Endocrine Diseases
- Sarcopenia
- Sarcopenic Obesity

## Interventions

- **DRUG:** GLP-1 Receptor Agonists

## Key facts

- **NCT ID:** NCT07703683
- **Lead sponsor:** Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-19
- **Primary completion:** 2056-12-31
- **Final completion:** 2056-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07703683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07703683, "Myokines as Potential Biomarkers and Drivers of Sarcopenia in Metabolic and Endocrine Diseases". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07703683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*